Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242801351> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4242801351 endingPage "2208" @default.
- W4242801351 startingPage "2208" @default.
- W4242801351 abstract "Objectives— Receptors for advanced glycation end products (RAGEs) play crucial roles in atherogenesis. Because tumor necrosis factor α (TNFα) is expressed and upregulates RAGE expression in atherosclerotic lesions, the TNFα-RAGE interaction might be involved in the inflammatory process of atherogenesis. On the other hand, an angiotensin II type-1 receptor blocker (ARB), widely used as an antihypertensive drug, has been reported to have also antiatherosclerotic effects. Thus we investigated whether an ARB exerts antiatherosclerotic effects via inhibiting the TNFα-RAGE interaction. Methods and Results— Stimulation of human endothelial cells with candesartan as well as olmesartan decreased TNFα-induced RAGE expression in both mRNA and protein levels along with the decrease in the activity of nuclear factor κB and the expression of inflammatory mediators such as vascular cell adhesion molecule (VCAM)-1. Both candesartan and olmesartan inhibited the binding of nuclear factor κB to the RAGE gene promoter. Furthermore, gene silencing of RAGE by RNA interference decreased the expression of TNFα-induced VCAM-1 in both mRNA and protein levels. Conclusions— RAGE contributes at least partially to the TNFα-induced VCAM-1 expression in both mRNA and protein levels. Blockade of angiotensin II receptors might exert antiatherosclerotic effects via reducing TNFα-RAGE interaction." @default.
- W4242801351 created "2022-05-12" @default.
- W4242801351 creator A5006066029 @default.
- W4242801351 creator A5011447361 @default.
- W4242801351 creator A5025504870 @default.
- W4242801351 creator A5029741432 @default.
- W4242801351 creator A5042667479 @default.
- W4242801351 creator A5058711256 @default.
- W4242801351 creator A5060490368 @default.
- W4242801351 creator A5064905150 @default.
- W4242801351 creator A5066544282 @default.
- W4242801351 creator A5077685039 @default.
- W4242801351 creator A5078668392 @default.
- W4242801351 creator A5080293775 @default.
- W4242801351 date "2006-10-01" @default.
- W4242801351 modified "2023-09-27" @default.
- W4242801351 title "Blockade of Angiotensin II Receptors Reduces the Expression of Receptors for Advanced Glycation End Products in Human Endothelial Cells" @default.
- W4242801351 doi "https://doi.org/10.1161/atvb.26.10.2208" @default.
- W4242801351 hasPublicationYear "2006" @default.
- W4242801351 type Work @default.
- W4242801351 citedByCount "4" @default.
- W4242801351 countsByYear W42428013512022 @default.
- W4242801351 crossrefType "journal-article" @default.
- W4242801351 hasAuthorship W4242801351A5006066029 @default.
- W4242801351 hasAuthorship W4242801351A5011447361 @default.
- W4242801351 hasAuthorship W4242801351A5025504870 @default.
- W4242801351 hasAuthorship W4242801351A5029741432 @default.
- W4242801351 hasAuthorship W4242801351A5042667479 @default.
- W4242801351 hasAuthorship W4242801351A5058711256 @default.
- W4242801351 hasAuthorship W4242801351A5060490368 @default.
- W4242801351 hasAuthorship W4242801351A5064905150 @default.
- W4242801351 hasAuthorship W4242801351A5066544282 @default.
- W4242801351 hasAuthorship W4242801351A5077685039 @default.
- W4242801351 hasAuthorship W4242801351A5078668392 @default.
- W4242801351 hasAuthorship W4242801351A5080293775 @default.
- W4242801351 hasBestOaLocation W42428013511 @default.
- W4242801351 hasConcept C104849204 @default.
- W4242801351 hasConcept C123915805 @default.
- W4242801351 hasConcept C126322002 @default.
- W4242801351 hasConcept C134018914 @default.
- W4242801351 hasConcept C147990577 @default.
- W4242801351 hasConcept C169760540 @default.
- W4242801351 hasConcept C170493617 @default.
- W4242801351 hasConcept C17991360 @default.
- W4242801351 hasConcept C185592680 @default.
- W4242801351 hasConcept C2778857457 @default.
- W4242801351 hasConcept C2779766728 @default.
- W4242801351 hasConcept C2780036600 @default.
- W4242801351 hasConcept C2908929049 @default.
- W4242801351 hasConcept C55493867 @default.
- W4242801351 hasConcept C71924100 @default.
- W4242801351 hasConcept C84393581 @default.
- W4242801351 hasConcept C86803240 @default.
- W4242801351 hasConcept C95444343 @default.
- W4242801351 hasConcept C98274493 @default.
- W4242801351 hasConceptScore W4242801351C104849204 @default.
- W4242801351 hasConceptScore W4242801351C123915805 @default.
- W4242801351 hasConceptScore W4242801351C126322002 @default.
- W4242801351 hasConceptScore W4242801351C134018914 @default.
- W4242801351 hasConceptScore W4242801351C147990577 @default.
- W4242801351 hasConceptScore W4242801351C169760540 @default.
- W4242801351 hasConceptScore W4242801351C170493617 @default.
- W4242801351 hasConceptScore W4242801351C17991360 @default.
- W4242801351 hasConceptScore W4242801351C185592680 @default.
- W4242801351 hasConceptScore W4242801351C2778857457 @default.
- W4242801351 hasConceptScore W4242801351C2779766728 @default.
- W4242801351 hasConceptScore W4242801351C2780036600 @default.
- W4242801351 hasConceptScore W4242801351C2908929049 @default.
- W4242801351 hasConceptScore W4242801351C55493867 @default.
- W4242801351 hasConceptScore W4242801351C71924100 @default.
- W4242801351 hasConceptScore W4242801351C84393581 @default.
- W4242801351 hasConceptScore W4242801351C86803240 @default.
- W4242801351 hasConceptScore W4242801351C95444343 @default.
- W4242801351 hasConceptScore W4242801351C98274493 @default.
- W4242801351 hasIssue "10" @default.
- W4242801351 hasLocation W42428013511 @default.
- W4242801351 hasOpenAccess W4242801351 @default.
- W4242801351 hasPrimaryLocation W42428013511 @default.
- W4242801351 hasRelatedWork W1964584012 @default.
- W4242801351 hasRelatedWork W1976929788 @default.
- W4242801351 hasRelatedWork W1983716718 @default.
- W4242801351 hasRelatedWork W2097154307 @default.
- W4242801351 hasRelatedWork W2097957153 @default.
- W4242801351 hasRelatedWork W2350886079 @default.
- W4242801351 hasRelatedWork W3193972101 @default.
- W4242801351 hasRelatedWork W330879772 @default.
- W4242801351 hasRelatedWork W4242801351 @default.
- W4242801351 hasRelatedWork W48752276 @default.
- W4242801351 hasVolume "26" @default.
- W4242801351 isParatext "false" @default.
- W4242801351 isRetracted "false" @default.
- W4242801351 workType "article" @default.